We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TETE
2376
DELISTED
Technology & Telecommunication Acquisition Corporation Class A Ordinary Shares
TETE
$465K ﹤0.01%
45,200
– –
TWCBW
2377
CALL
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
$465K ﹤0.01%
47,010
– –
LUNA
2378
DELISTED
Luna Innovations Incorporated
LUNA
$463K ﹤0.01%
+52,628
New +$334K
APPF icon
2379
AppFolio
APPF
$6.62B
$458K ﹤0.01%
+4,342
New +$483K
MANU icon
2380
Manchester United
MANU
$4.03B
$457K ﹤0.01%
19,600
-19,300
-50% -$323K
MGPI icon
2381
MGP Ingredients
MGPI
$403M
$454K ﹤0.01%
4,267
-5,710
-57% -$638K
CUTR
2382
DELISTED
Cutera, Inc.
CUTR
$454K ﹤0.01%
10,261
-2,639
-20% -$120K
ORMP icon
2383
Oramed Pharmaceuticals
ORMP
$162M
$450K ﹤0.01%
37,399
+8,990
+32% +$69.9K
IHE icon
2384
iShares US Pharmaceuticals ETF
IHE
$1.49B
$448K ﹤0.01%
7,218
-1,200
-14% -$72.2K
TPL icon
2385
Texas Pacific Land
TPL
$26.9B
$448K ﹤0.01%
1,719
-4,671
-73% -$1.24M
EL icon
2386
Estee Lauder
EL
$30.4B
$447K ﹤0.01%
1,800
-367,218
-100% -$82M
EGRX
2387
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$447K ﹤0.01%
+15,276
New +$486K
INBK icon
2388
First Internet Bancorp
INBK
$233M
$446K ﹤0.01%
+18,356
New +$485K
AL
2389
DELISTED
Air Lease Corp
AL
$445K ﹤0.01%
+11,590
New +$417K
TEVA icon
2390
Teva Pharmaceuticals
TEVA
$40.4B
$445K ﹤0.01%
48,771
+1,273
+3% +$11.1K
PCT icon
2391
PureCycle Technologies
PCT
$1.19B
$444K ﹤0.01%
65,700
-1,030,012
-94% -$7.43M
PSNL icon
2392
Personalis
PSNL
$1.25B
$439K ﹤0.01%
221,823
-215,698
-49% -$543K
VTEX icon
2393
VTEX
VTEX
$767M
$437K ﹤0.01%
116,523
-372,075
-76% -$1.42M
FRBK
2394
DELISTED
Republic First Bancorp Inc
FRBK
$434K ﹤0.01%
202,030
-58,275
-22% -$155K
CANO.WS
2395
CALL
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$434K ﹤0.01%
317,010
-182,990
-37% -$159K
IDT icon
2396
IDT Corp
IDT
$1.67B
$433K ﹤0.01%
+15,365
New +$412K
TSM icon
2397
CALL
TSMC
TSM
$1.94T
$432K ﹤0.01%
5,800
-73,900
-93% -$5.35M
EVEX.WS icon
2398
CALL
Eve Holding Inc Warrants
EVEX.WS
$45.2M
$432K ﹤0.01%
59,941
-30,059
-33% -$10.4K
EH
2399
EHang Holdings
EH
$375M
$428K ﹤0.01%
49,913
-425,129
-89% -$2.22M
SSTK icon
2400
Shutterstock
SSTK
$209M
$427K ﹤0.01%
8,100
+169
+2% +$8.61K
94 95
96
97 98

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.